Type 2 diabetes trials in Türkiye
16 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
No phaseRecruitingResearch participation
Effect of Sensory Training on Functional Performance, Balance, Gait in Type 2 Diabetic Individuals With Neuropathy
- Where
- Van
- Age
- 35 years to 65 years
- People
- 40
- Run by
- Aylin DEMİR
See details and how to joinNCT06979401Registry updated 2026-11-09
Phase 3RecruitingTrial-stage medicine
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Adana, Ankara, Antalya, Istanbul, Izmir, Sariçam
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058EU 2025-523106-32-00Registry updated 2026-11-09
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Ankara, Antalya, Center, Istanbul
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509EU 2025-523295-23-00Registry updated 2026-11-09
No phaseRecruitingResearch participation
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
- Where
- Denizli
- Age
- 18 years to 65 years
- People
- 30
- Run by
- Pamukkale University
See details and how to joinNCT07924436Registry updated 2026-11-09
No phaseRecruitingResearch participation
Ocular Changes in Patients Using Tirzepatide or Semaglutide
- Where
- Istanbul
- Age
- 18 years and over
- People
- 40
- Run by
- Istanbul University
See details and how to joinNCT07924618Registry updated 2026-11-09
No phaseNot yet recruitingResearch participation
Comparison of Functional Inspiratory Muscle Training and Combined Exercise Training in Individuals With Type 2 Diabetes
- Where
- Istanbul
- Age
- 40 years to 65 years
- People
- 39
- Run by
- İrem Çaylak Yetüt
See details and how to joinNCT07921901Registry updated 2026-11-06
Phase 3Not yet recruitingTrial-stage medicine
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Adana, Ankara, Antalya, Diyarbakır, Eskişehir, Istanbul, Kayseri, Kocaeli, Yüreğir
- Age
- 45 years to 64 years
- People
- 3,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633EU 2026-525919-14-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Ankara, Gaziantep, Istanbul, Konya
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109EU 2025-523941-81-00Registry updated 2026-10-30
Phase 3RecruitingTrial-stage medicine
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Edirne, Istanbul, Izmir, Kayseri, Malatya, Zonguldak
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473EU 2025-521188-11-00Registry updated 2026-10-28
No phaseRecruitingResearch participation
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
- Where
- Adana, Bakirkoy Istanbul, Basaksehir / Istanbul, Istanbul, Ümraniye / İstanbul
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06704672Registry updated 2026-10-26
Phase 3RecruitingTrial-stage medicine
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Adana, Adapazarı, Ankara, Antalya, Istanbul
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803Registry updated 2026-10-13
Phase 3RecruitingTrial-stage medicine
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Adana, Ankara, Antalya, Bakırköy, Gaziantep, Kayseri, Yüreğir
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135EU 2025-523940-12-00Registry updated 2026-09-02
Phase 3RecruitingTrial-stage medicine
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Adana, Adana /yüreği̇r, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli, Nilüfer/Bursa, Odunpazarı /Eskişehir, Sivas, Sur / Diyarbakır
- Age
- 45 years and over
- People
- 1,778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335Registry updated 2026-09-01
Phase 3RecruitingTrial-stage medicine
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Where
- Adana, Ankara, Bursa, Izmir, Kayseri, Samsun
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662044EU 2025-523936-37-00Registry updated 2026-08-31
No phaseRecruitingResearch participation
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Where
- Adana, Ankara, Gaziantep, Istanbul, Kayseri
- Age
- 18 years and over
- People
- 2,150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07606066Registry updated 2026-08-25
Phase 2RecruitingTrial-stage medicine
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli
- Age
- 18 years and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698EU 2024-510846-15-00Registry updated 2026-03-11
All Type 2 diabetes trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.